iSOFT Wins $14 Million New Business in Europe

iSOFTiSOFT, an IBA Health Group company (ASX: IBA) announced that it has secured new business together with renewal of contracts worth AS$14 million in the UK and central Europe over the past month. iSOFT Northern Europe has had a record month of new orders worth AS$5 million (€3.1 million), while iSOFT UK and Ireland has agreed contract extensions worth AS$9 million (£4.22 million) for ongoing maintenance and support.

New orders for iSOFT Northern Europe included six contracts in Germany for hospital information systems. The company also won four orders for radiology information systems with three hospitals in Germany and with Euromedic in Switzerland for three of its diagnostic centres.

Four contracts for laboratory information systems were also secured with three hospitals in Germany and Gemotest in Russia.

Albertinen Gruppe in Hamburg has agreed a contract for iSOFT's Professional Planner for intelligent financial planning across three sites.

In the UK and Ireland, Harrogate Healthcare NHS Trust and South Tyneside Healthcare NHS Trust have agreed five year licence and support contracts for iSOFT patient management systems and the Southern Health Board in Ireland and St George's Healthcare NHS Trust in London have renewed support agreements for iSOFT laboratory information systems.

Gary Cohen, IBA's Executive Chairman and CEO, said: "We have had an excellent month of new business in Northern Europe, a record for the company and clear evidence of a renewed confidence in iSOFT."

Related news articles:

About IBA Health Group
IBA Health Group Limited (ASX-IBA) is the largest specialist information technology company listed on the Australian Securities Exchange.

IBA builds software applications for healthcare. We work with healthcare professionals to design and build solutions that answer all of the difficult questions posed by today's care delivery challenges. Our solutions act as a catalyst for change, supporting the exchange of critical information across diverse care settings and participant organisations. We are the leader in the provision of advanced application solutions in modern healthcare economies around the world.

Today, over 13,000 provider organisations in 35 countries across five continents use IBA's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of our market and anticipation of evolving requirements. Our business is driven by the collective talent, experience and commitment of over 3,500 healthcare IT experts around the globe.

A global network of IBA subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result we offer our customers comprehensive knowledge of local market requirements, in terms of culture, language, working practice, healthcare regulation and organisational structure.

For more information on IBA Health, please visit the Company's website at www.ibahealth.com.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...